Abstract:Interactions between the gut microbiota and host immunity are sophisticated, dynamic, and host-dependent. Scientists have recently conducted research showing that disturbances in the gut bacterial community can lead to a decrease in some metabolites and, consequently, to behaviors such as depression. Exposure to stressors dropped the relative abundance of bacteria in the genus Bacteroides while soaring the relative abundance of bacteria in the genus Clostridium, Coprococcus, Dialister, and Oscillibacter, which were also reduced in people with depression. Microbiota and innate immunity are in a bilateral relationship. The gut microbiota has been shown to induce the synthesis of antimicrobial proteins such as catalysidins, type C lectins, and defensins. Probiotic bacteria can modulate depressive behavior through GABA signaling. The gut microbiome produces essential metabolites such as neurotransmitters, tryptophan metabolites, and short-chain fatty acids (SCFAs) that can act on the CNS. In the case of dysbiosis, due to mucin changes, the ratio of intestinal-derived molecules may change and contribute to depression. Psychotropics, including Bifidobacterium longum NCC3001, Clostridium butyricum CBM588, and Lactobacillus acidophilus, have mental health benefits, and can have a positive effect on the host-brain relationship, and have antidepressant effects. This article reviews current studies on the association between gut microbiota dysbiosis and depression. Comprehensively, these findings could potentially lead to novel approaches to improving depressive symptoms via gut microbiota alterations, including probiotics, prebiotics, and fecal microbiota transplantation.

Potential role of gut microbiota in major depressive disorder: A review

Epigenetics in depression and gut-brain axis: A molecular crosstalk

The Gut Microbiota and Major Depressive Disorder: Current Understanding and Novel Therapeutic Strategies

The Role of the Gut Microbiota in the Development and Progression of Major Depressive and Bipolar Disorder

Mood and Microbes: a Comprehensive Review of Intestinal Microbiota’s Impact on Depression

Mechanistic Insights into the Link between Gut Dysbiosis and Major Depression: An Extensive Review

Mood and microbes: a comprehensive review of intestinal microbiota's impact on depression

Gut-brain axis: A matter of health and disease in neuropsychiatric disorders…!

Gut microbiota and its metabolites in depression: from pathogenesis to treatment

The Role of Microbiota in Depression - a brief review

Depression-associated gut microbes, metabolites and clinical trials

Investigating the bacterial profiles of Lactobacillus, Bifidobacterium, Actinobacteria, Fusobacterium, Firmicutes, and Bacteroides in stool samples from patients with severe depression and healthy individuals

Depressed gut? The microbiota-diet-inflammation trialogue in depression

Human Gut Microbiota for Diagnosis and Treatment of Depression

The Gut-Brain Axis and Its Role in Depression

Association between major depressive disorder and gut microbiota dysbiosis

Gut microbiota modulates neurotransmitter and gut-brain signaling

Gut microbiota-derived short-chain fatty acids and depression: deep insight into biological mechanisms and potential applications

A Reciprocal Link Between Gut Microbiota, Inflammation and Depression: A Place for Probiotics?

Baseline gut microbiota profiles affect treatment response in patients with depression

Impacts of microbiota and its metabolites through gut-brain axis on pathophysiology of major depressive disorder